Trademark: 85583416
Word
MOLECULARHEALTH BECAUSE PRECISION MATTERS
Status Date
Wednesday, January 13, 2016
Filing Date
Thursday, March 29, 2012
Abandoned Date
Thursday, December 3, 2015
35 Data collection services for business purposes, namely, the collection and systematic sorting of clinical and patient data comprising patient specific molecular and/or genomic data, patient specific clinical data and scientific clinical studies; data collection services for business purposes, namely, the collection of mathematic and statistical data, clinical data, patient data and data of clinical studies relating to clinical response to drug treatments; data and text processing services, namely, the processing of patient specific information, molecular test results and clinical studies data via computer
42 Data collection for research purposes, namely, the collection and systematic sorting of clinical and patient data comprising patient specific molecular and/or genomic data, patient specific clinical data and scientific clinical studies; data collection for research purposes, namely, the collection of mathematic and statistical data, clinical data, patient data and data of clinical studies relating to clinical response to drug treatments; compiling data for research purposes in the field of medical science, namely, compiling patient specific molecular and genomic data, patient specific clinical data and scientific clinical studies; scientific, technical and research services for medical purposes in the field of medical diagnostic and treatment research; providing medical and scientific research information and scientific consulting in the fields of pharmaceutical side effects, genomics, biological medicine and translational medicine; providing an online database comprised of medical, pharmaceutical, biological and genomic information for scientific research purposes; providing an online searchable database in the fields of medical, pharmaceutical, biological, clinical and genomic information for scientific research purposes; providing an online searchable database in the fields of biological medical, translational medicine, interventional epidemiology, bioinformatics, clinical information technology, genomic data and genomic sequence analysis for scientific research purposes; design and development of computer software in the fields of biology, medicine, and bioinformatics; design and development of computer software for integration of patient specific data, molecular test results, clinical studies and scientific results; providing online non-downloadable computer software for use by healthcare professionals for medical diagnostic and treatment research ; design and development of databases featuring biomarker data; providing an online searchable database for clinical and scientific research in the field of medical, diagnostic and treatment research; software as a Service (SAAS) services featuring software for providing information for patient treatment by enabling the retrieval and correlation of genomic data, drug protocols, clinical profiling and integration and statistical analysis of data for medical purposes; providing online non-downloadable software for retrieval and correlation of genomic data, drug protocols, clinical profiling and integration and statistical analysis of data for medical diagnostic and treatment research purposes; medical research and scientific research and scientific consulting services, namely, designing and conducting drug safety and dosage assessment and drug compatibility studies in the field of cancer therapy for others
44 Providing an online database featuring medical information and diagnostic, prophylactic and therapeutic properties of pharmaceuticals, and genomic information as it relates to medical diagnosis and treatment; pharmaceutical consulting services in pharmaceuticals and genetics in relation to patient medical treatment options; medical consulting services with respect to the treatment and diagnosis of individuals in the fields of clinical pharmacology and the analysis of dose effect relationships for treatment purposes; providing pharmaceutical information, namely, information about drug safety and drug compatibility in relation to cancer therapy and the treatment of individual patients; medical consulting services in the fields of patient treatment and treatment protocols; consulting services in the field of pharmaceuticals and genetics, namely, conducting drug safety and dosage assessment and in drug compatibility studies in the field of cancer treatment therapy for others relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals
Jan 13, 2016
Abandonment Notice Mailed - Failure To Respond
Jan 13, 2016
Abandonment - Failure To Respond Or Late Response
Oct 19, 2015
Assigned To Examiner
Jun 2, 2015
Notification Of Non-Final Action E-Mailed
Jun 2, 2015
Non-Final Action E-Mailed
Jun 2, 2015
Non-Final Action Written
May 12, 2015
Teas/Email Correspondence Entered
May 12, 2015
Correspondence Received In Law Office
Apr 28, 2015
Teas Response To Suspension Inquiry Received
Oct 28, 2014
Notification Of Inquiry As To Suspension E-Mailed
Oct 28, 2014
Inquiry To Suspension E-Mailed
Oct 28, 2014
Suspension Inquiry Written
Oct 1, 2014
Lie Checked Susp - To Atty For Action
Aug 20, 2014
Automatic Update Of Assignment Of Ownership
Mar 31, 2014
Notification Of Letter Of Suspension E-Mailed
Mar 31, 2014
Letter Of Suspension E-Mailed
Mar 31, 2014
Suspension Letter Written
Mar 18, 2014
Teas/Email Correspondence Entered
Mar 18, 2014
Correspondence Received In Law Office
Mar 14, 2014
Teas Response To Suspension Inquiry Received
Sep 17, 2013
Notification Of Inquiry As To Suspension E-Mailed
Sep 17, 2013
Inquiry To Suspension E-Mailed
Sep 17, 2013
Suspension Inquiry Written
Sep 9, 2013
Lie Checked Susp - To Atty For Action
Mar 7, 2013
Notification Of Letter Of Suspension E-Mailed
Mar 7, 2013
Letter Of Suspension E-Mailed
Mar 7, 2013
Suspension Letter Written
Mar 7, 2013
Examiner's Amendment Entered
Mar 7, 2013
Notification Of Examiners Amendment E-Mailed
Mar 7, 2013
Examiners Amendment E-Mailed
Mar 7, 2013
Examiners Amendment -Written
Jan 31, 2013
Teas/Email Correspondence Entered
Jan 31, 2013
Correspondence Received In Law Office
Jan 22, 2013
Assigned To Lie
Jan 21, 2013
Teas Change Of Correspondence Received
Jan 21, 2013
Teas Response To Office Action Received
Jul 22, 2012
Notification Of Non-Final Action E-Mailed
Jul 22, 2012
Non-Final Action E-Mailed
Jul 22, 2012
Non-Final Action Written
Jul 10, 2012
Assigned To Examiner
Apr 4, 2012
New Application Office Supplied Data Entered In Tram
Apr 2, 2012
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
